Fresenius Medical Care
PROPERTY OVERVIEW
Ownership: Public
Credit Rating: S&P: BBB-
Ticker: NYSE: FMS
Sector: Healthcare
COMPANY DESCRIPTION
Fresenius Medical Care North America is a division of Fresenius
Medical Care AG & Co. KGAA (NYSE: FMS), the world’s largest
integrated provider of products and services for individuals
undergoing dialysis because of chronic kidney failure, a condition
that affects more than 2.5 million individuals worldwide.
Fresenius Medical Care North America is a major provider of
kidney dialysis services and renal care products. They provide
products, dialysis care services, education and support for
Chronic Kidney Disease (CKD), including treatment options for
later stage CKD.
Fresenius Medical Care provides renal services to over 270,000
people annually worldwide through a network of over 3,400
facilities.
The Company employs over 104,000 individuals and maintains a
U.S. Corporate Headquarters in Waltham, MA.
North American Revenue accounts for over 66% of the total
worldwide revenue generated by the company.
In 2015, the parent company, Fresenius Medical Care, posted
net revenues of $16.73 billion dollars.
